$REGN Stock Reminder: Regeneron Investors with Losses are Reminded of the Filed Class Action and Upcoming September 14 Court Deadline
Bleichmar Fonti & Auld LLP issued a reminder regarding a securities fraud class action lawsuit filed against Regeneron, setting a lead plaintiff deadline of September 14, 2026. The lawsuit alleges Regeneron misled investors regarding the success of its Phase III Fianlimab-Libtayo clinical trial, which failed to reach statistical significance and caused significant stock drops in April and May 2026.
Key figures
- Stock drop may 15
- 9.8%
- Stock drop april 29
- 6.2%
- Price decline may 15
- $68.57 per share
- Price decline april 29
- $45.41 per share
- Lead plaintiff deadline
- September 14, 2026
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.